CE/CME Statement

You must login or register to view this form.

CE/CME Statement

Not started
CE/CME Statement
Open/Close details
- Required
Not started
Sa1131: D’Haens et al. PYRAMID Registry: an Observational Study...
Open/Close details
- Optional
Not started
Sa1228: Sofi et al. Predictors of Relapse Following Withdrawal of Anti-TNF Agents...
Open/Close details
- Optional
Not started
749: Regueiro et al. Infliximab for Prevention of Recurrence...
Open/Close details
- Optional
Not started
Tu1313: Armuzzi et al. Infliximab is more effective than azathioprine...
Open/Close details
- Optional
Not started
Sa1125: Shah et al. Anti-TNF agents may pose a higher risk of infection...
Open/Close details
- Optional
Not started
Sa1118: Kirchgesner et al. Withdrawing or continuing maintenance treatment with thiopurines...
Open/Close details
- Optional
Not started
Sa1128: Chen et al. Incident Infectious and Malignant Adverse Event Risk...
Open/Close details
- Optional
Not started
Sa1239: Al Alawi et al. Does failure to respond to one anti-TNF agent...
Open/Close details
- Optional
Not started
Tu1305: Rubin et al. Analysis of Outcomes After Non-Medical Switching...
Open/Close details
- Optional
Not started
Sa1262: Feagan et al. Patient-Reported Outcomes...
Open/Close details
- Optional
Not started
Program Evaluation
Open/Close details
- Required
Not started
Credit
Open/Close details
- Optional
Not started
Certificate
Open/Close details
- Optional

Expand / Minimize

Annenberg Center